Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
American Journal of Respiratory and Critical Care Medicine
|
September 20, 2017
Randomized Controlled Trial of Urokinase versus Placebo for Nondraining Malignant Pleural Effusion
Eleanor K Mishra, Amelia O Clive, Genevieve H Wills, et al.
The Lancet. Respiratory Medicine
|
October 11, 2021
Role of thoracic ultrasonography in pleurodesis pathways for malignant pleural effusions (SIMPLE): an open-label, randomised controlled trial
Ioannis Psallidas, Maged Hassan, Ahmed Yousuf, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
January 16, 2024
Cost-utility analysis of molnupiravir for high-risk, community-based adults with COVID-19: an economic evaluation of the PANORAMIC trial
May Ee Png, Victoria Harris, Jenna Grabey, et al.
JAMA
|
January 1, 2016
Effect of Opioids vs NSAIDs and Larger vs Smaller Chest Tube Size on Pain Control and Pleurodesis Efficacy Among Patients With Malignant Pleural Effusion: The TIME1 Randomized Clinical Trial
Najib M Rahman, Justin Pepperell, Sunita Rehal, et al.
American Journal of Respiratory and Critical Care Medicine
|
October 11, 2023
Early Video-assisted Thoracoscopic Surgery or Intrapleural Enzyme Therapy in Pleural Infection: A Feasibility Randomized Controlled Trial. The Third Multicenter Intrapleural Sepsis Trial-MIST-3
Eihab O Bedawi, Dionisios Stavroulias, Emma Hedley, et al.
The Lancet. Infectious Diseases
|
September 12, 2024
Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial
Victoria Harris, Jane Holmes, Oghenekome Gbinigie-Thompson, et al.
BMJ Open
|
August 7, 2023
Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease
Oghenekome Gbinigie, Emma Ogburn, Julie Allen, et al.
The European Respiratory Journal
|
July 18, 2020
Prospective validation of the RAPID clinical risk prediction score in adult patients with pleural infection: the PILOT study
John P Corcoran, Ioannis Psallidas, Stephen Gerry, et al.
The Lancet. Infectious Diseases
|
October 7, 2022
Antibiotic review kit for hospitals (ARK-Hospital): a stepped-wedge cluster-randomised controlled trial
Martin J Llewelyn, Eric P Budgell, Magda Laskawiec-Szkonter, et al.
Lancet (London, England)
|
December 25, 2022
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
Christopher C Butler, F D Richard Hobbs, Oghenekome A Gbinigie, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
American Journal of Respiratory and Critical Care Medicine
|
September 20, 2017
Randomized Controlled Trial of Urokinase versus Placebo for Nondraining Malignant Pleural Effusion
Eleanor K Mishra, Amelia O Clive, Genevieve H Wills, et al.
The Lancet. Respiratory Medicine
|
October 11, 2021
Role of thoracic ultrasonography in pleurodesis pathways for malignant pleural effusions (SIMPLE): an open-label, randomised controlled trial
Ioannis Psallidas, Maged Hassan, Ahmed Yousuf, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
January 16, 2024
Cost-utility analysis of molnupiravir for high-risk, community-based adults with COVID-19: an economic evaluation of the PANORAMIC trial
May Ee Png, Victoria Harris, Jenna Grabey, et al.
JAMA
|
January 1, 2016
Effect of Opioids vs NSAIDs and Larger vs Smaller Chest Tube Size on Pain Control and Pleurodesis Efficacy Among Patients With Malignant Pleural Effusion: The TIME1 Randomized Clinical Trial
Najib M Rahman, Justin Pepperell, Sunita Rehal, et al.
American Journal of Respiratory and Critical Care Medicine
|
October 11, 2023
Early Video-assisted Thoracoscopic Surgery or Intrapleural Enzyme Therapy in Pleural Infection: A Feasibility Randomized Controlled Trial. The Third Multicenter Intrapleural Sepsis Trial-MIST-3
Eihab O Bedawi, Dionisios Stavroulias, Emma Hedley, et al.
The Lancet. Infectious Diseases
|
September 12, 2024
Health outcomes 3 months and 6 months after molnupiravir treatment for COVID-19 for people at higher risk in the community (PANORAMIC): a randomised controlled trial
Victoria Harris, Jane Holmes, Oghenekome Gbinigie-Thompson, et al.
BMJ Open
|
August 7, 2023
Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease
Oghenekome Gbinigie, Emma Ogburn, Julie Allen, et al.
The European Respiratory Journal
|
July 18, 2020
Prospective validation of the RAPID clinical risk prediction score in adult patients with pleural infection: the PILOT study
John P Corcoran, Ioannis Psallidas, Stephen Gerry, et al.
The Lancet. Infectious Diseases
|
October 7, 2022
Antibiotic review kit for hospitals (ARK-Hospital): a stepped-wedge cluster-randomised controlled trial
Martin J Llewelyn, Eric P Budgell, Magda Laskawiec-Szkonter, et al.
Lancet (London, England)
|
December 25, 2022
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
Christopher C Butler, F D Richard Hobbs, Oghenekome A Gbinigie, et al.
Page
of 4